Genzyme Corporation (NASDAQ: GENZ) announced that the FDA informed the company late Thursday that it will re-inspect the company’s Allston ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE